Hydrogen deuterium exchange mass spectrometry for the masses

Importance of the Topic

Hydrogen deuterium exchange mass spectrometry (HDX-MS) provides a powerful approach to investigate protein structure, dynamics and interactions in solution. It overcomes the limitations of traditional techniques—such as the need for large sample amounts, crystallization or size restrictions in NMR—by delivering region-specific insights into protein conformations, folding intermediates, ligand binding sites and allosteric effects under near-native conditions.

Objectives and Study Overview

This white paper introduces the principles of HDX-MS, highlights recent advances in instrumentation and workflows, and demonstrates how continuous labeling and pulsed HDX experiments yield information on protein conformations, dynamics, binding interfaces, intrinsic disorder and aggregation pathways. It also explains the complementary role of HDX-MS alongside crystallography, cryo-EM, NMR and crosslinking-MS for integrative structural biology.

Methodology and Instrumentation

All HDX-MS workflows begin with incubation of the target protein or complex in deuterated buffer, allowing backbone amide hydrogens to exchange with deuterium. Exchange is quenched by lowering pH and temperature. Two main strategies are used:

• Bottom-up HDX-MS: Proteins are digested by acid proteases (e.g., pepsin) in solution or on an immobilized column. Peptides are separated by reversed-phase chromatography and analyzed by high-resolution MS, with optional ETD MS/MS for single-residue resolution and minimal scrambling.
• Intact/Top-down HDX-MS: Deuterated proteins are introduced intact into the mass spectrometer after minimal separation (e.g., C4 chromatography). Intact mass shifts report global uptake, while ETD or UVPD fragmentation localizes deuterium at the amino acid level.

Key instrumentation includes ultra-high resolution Orbitrap mass spectrometers for resolving isotopic envelopes, H/D-X PAL™ automated sampler systems for precise labeling and quenching, and advanced fragmentation options (ETD, EThcD, UVPD). BioPharma Finder™ software enables automated peptide identification, deuterium uptake calculation and protection factor modeling.

Main Results and Discussion

– Conformational analysis: HDX-MS maps protected (slow-exchanging) versus solvent-exposed (fast-exchanging) regions to reveal static and dynamic conformations. Continuous labeling experiments on cytochrome c show time-dependent uptake maps that correlate with loop flexibility and core stability.
– Protein dynamics: Differential HDX-MS across time or conditions uncovers intermediate structures in folding/unfolding pathways. Pulsed labeling captures transient states on the millisecond to second timescale.
– Ligand binding and allostery: Comparison of apo and holo forms of calmodulin illustrates reduced deuterium incorporation at calcium binding sites and remote allosteric regions, highlighting long-range conformational coupling.
– Intrinsic disorder: Adjusting labeling pH extends the temporal window to probe highly flexible, disordered segments that exchange too rapidly at physiological pH.
– Aggregation studies: Therapeutic monoclonal antibody (Trastuzumab) aggregates induced by low pH exhibit increased deuterium uptake in light and heavy chain domains, pinpointing aggregation-prone regions and structural destabilization.

Practical Benefits and Applications of the Method

• Size independence: Effective for small proteins to megadalton assemblies.
• Sample efficiency: Low microgram quantities suffice for detailed mapping.
• Native conditions: Measurements reflect biologically relevant conformations.
• Complementarity: Integrates seamlessly with crystallography, cryo-EM, NMR and XL-MS for comprehensive models.
• Biotherapeutic development: Guides rational drug design, formulation stability and quality control by monitoring conformational integrity and aggregation.

Future Trends and Potential Applications

Innovations in MS hardware (faster acquisition, PTCR, advanced dissociation modes), automation of sample handling and real-time data analysis will further streamline HDX-MS workflows. In vivo HDX labeling, machine learning–driven interpretation of protection factors and integrative modeling platforms promise deeper insights into complex biological systems, transient protein assemblies and conformational diseases.

Conclusion

HDX-MS has matured into an accessible, sensitive and versatile technique to characterize protein structures, dynamics and interactions under near-physiological conditions. Advances in instrumentation, fragmentation methods and software support enable high spatial and temporal resolution, fostering its adoption beyond specialist laboratories into mainstream research, biopharma and quality control settings.

References

1. Huang R.Y., Chen G. (2014) Higher order structure characterization of protein therapeutics by hydrogen/deuterium exchange mass spectrometry. Anal Bioanal Chem. 406(26):6541–6558.
2. Rand K.D., Zehl M., Jorgensen T.J.D. (2014) Measuring the hydrogen/deuterium exchange of proteins at high spatial resolution by MS: overcoming gas-phase scrambling. Acc Chem Res. 47:3018–3027.
3. Abzalimov R.R., Kaltashov I.A. (2010) Controlling hydrogen scrambling in multiply charged protein ions during collisional activation: implications for top-down HDX-MS. Anal Chem. 82:942–950.
4. Ferguson P.L. et al. (2007) Hydrogen/deuterium scrambling during Q-TOF MS/MS of a zinc-binding protein domain. Anal Chem. 79:153–160.
5. Hagman C. et al. (2004) Inter-molecular migration during collisional activation monitored by HDX FT-ICR tandem MS. J Am Soc Mass Spectrom. 15:639–646.
6. Rand K.D., Jorgensen T.J. (2007) Development of a peptide probe for hydrogen scrambling upon gas-phase fragmentation. Anal Chem. 79(22):8686–8693.
7. Rand K.D. et al. (2009) Protein HDX measured at single-residue resolution by ETD MS. Anal Chem. 81(14):5577–5584.
8. Trabjerg E., Nazari Z.E., Rand K.D. (2018) Conformational analysis of complex protein states by HDX-MS: challenges and emerging solutions. Trends Analyt Chem. 106:125–128.
9. Pan J. et al. (2010) Characterizing short-lived protein folding intermediates by top-down HDX-MS. Anal Chem. 82(20):8591–8597.
10. Konermann L., Simmons D.A. (2003) Protein-folding kinetics and mechanisms studied by pulse-labeling and MS. Mass Spectrom Rev. 22(1):1–26.
11. Miranker A. et al. (1993) Detection of transient protein folding populations by MS. Science. 262(5135):896–900.
12. Zhang Z., Zhang A., Xiao G. (2012) Improved protein HDX-MS platform with fully automated data processing. Anal Chem. 84(11):4942–4949.
13. Zheng J. et al. (2019) Protein dynamics and conformational changes explored by HDX-MS. Curr Opin Struct Biol. 58:304–313.
14. Mayne L. et al. (2011) Many overlapping peptides for protein HDX experiments by fragment separation-MS. J Am Soc Mass Spectrom. 22(11):1898–1905.
15. Goswami D. et al. (2013) Time window expansion for HDX analysis of an intrinsically disordered protein. J Am Soc Mass Spectrom. 24:1584–1592.